|
613 First
pharmacy-only triptan launched by GSK Sumatriptan tablets
will soon be available over the counter following the launch of Imigran
Recovery (sumatriptan; GlaxoSmithKline) 50mg tablets as a pharmacy-only
medicine this week ...more
613 Controlled
Drug prescription change planned Consultation has started
on changing the law so that requirements for community pharmacies to
keep private prescriptions are not made more onerous by new Controlled
Drugs record-keeping requirements brought in as a result of the Shipman
Inquiry ...more
613 New guidance
on counterfeit medicines New guidance on counterfeit medicines
has been produced for pharmacists jointly by the Royal Pharmaceutical
Society and the Medicines and Healthcare products Regulatory Agency ...more
613 Community
pharmacy may no longer be a family-friendly career Some female
community pharmacists face difficulties meeting domestic commitments
owing to long working hours, supervisory requirements and staffing problems,
according to research presented at the Pharmacy Practice Research Trust's
biennial awards seminar in London earlier this month ...more
614 Minor label
changes made easier Manufacturers of over-the-counter medicines
are now allowed to make technical changes to their packaging, labelling
and patient information leaflets without having to get detailed approval
from the Medicines and Healthcare products Regulatory Agency first ...more
614 New post
to develop pharmacist prescribing Pharmacist prescribing is
to be developed with the creation of a new post in Scotland ...more
614 Non-medical
prescribers link up to have a single voice Health professionals have formed a new group — the Confederation for Prescribers — to enable them to speak about prescribing issues with a common voice
...more
614 Pharmacy
category increases public access to medicines There is a tendency for more products to be made available without a prescription in countries that have certain products that are only available through pharmacies, according to an article published in this month's issue of the International Journal of Pharmacy Practice
...more
614 Final preparations
for minor ailment service in Scotland NHS boards in Scotland
have been authorised to supply stocks of CP2 prescription forms to community
pharmacists for the minor ailment service (MAS). Patients will be able
to register for the service on 1 June, although consultations are not
allowed until 1 July ...more
615 Service redesign
needs to target unscheduled care Practice-based commissioning
offers a great opportunity for community pharmacists to be co-providers
of services with GP practices but they need to be proactive, according
to Donal Hynes, medical director at Somerset Coast Primary Care Trust
and co-vice chairman of NHS Alliance ...more
615 Pharmacists'
role in managing musculoskeletal complaints Community pharmacists
can play a central part in the management of musculoskeletal complaints,
draft guidance from the Welsh Assembly Government suggests ...more
615 Oral rotavirus
vaccine for childhood immunisation launched A vaccine to provide
protection for infants against rotavirus gastroenteritis has been launched
by GlaxoSmithKline ...more
615 Pilot of
drug consumption rooms recommended by charity Drug consumption rooms — where dependent drug users can self-administer under supervised, hygienic conditions — can prevent drug-related death and improve the general health of drug misusers, and should be piloted in the UK, according to a report released this week
...more
615 Importance
of adherence in osteoporosis patients highlighted in new report The importance of adherence to long-term osteoporosis therapy — namely bisphosphonate medicines — has been highlighted in a new report released this week by the International Osteoporosis Foundation
...more
615 CPW chairman
re-elected Phil Parry has been re-elected chairman of Community Pharmacy Wales for 2006–07 and Peter John Jones has been re-elected vice-chairman
...more
|
616 ABPI questions
whether NICE is working as it should Postcode prescribing
in the NHS continues because of failure in the National Institute for
Health and Clinical Excellence's interactions with the health system,
the Association of the British Pharmaceutical Industry argued last week
...more
616 Doctors spark
debate about alternative medicine in the NHS Objections to
the use of NHS money to fund “unproven or disproved” complementary
and alternative medicine treatments have been raised in a letter written
this week to NHS trust chief executives by a group of prominent UK doctors
and scientists ...more
616 Burnham launches
new primary care research facility A new institution for primary
care research was launched by health minister Andy Burnham last week.
It is the first health research school established within the new National
Institute for Health Research (NIHR), launched on 1 April ...more
616 Register
all human studies, says WHO Pharmaceutical companies have
been called upon to register all drug studies involving human testing,
whether on patients or healthy volunteers ...more
617 Give three
quarters of men statins for 90 pc benefit A comparison of
UK, European and US recommendations for use of statins in the primary
prevention of vascular disease reveals that over three quarters of adult
men need to be treated to gain maximum population benefit ...more
617 NSAIDs may
contribute to heart failure admissions Use of non-steroidal
anti-inflammatory drugs (NSAIDs) by older people is associated with an
increased risk of hospital admission for heart failure, a study shows
...more
617 Dipyridamole
and aspirin for stroke prevention A combination of aspirin
and dipyridamole is more effective than aspirin alone in the secondary
prevention of stroke, according to research ...more
617 Atrial fibrillation
a risk with high-dose corticosteroid use Patients aged over
55 years who take high-dose oral corticosteroid therapy are at increased
risk of atrial fibrillation, a study reveals ...more
|
The
Pharmaceutical Journal